Similar to the PTEN tumor suppressor, differences in the types of neoplasias observed in these animal models might be due to the regulation of WWOX by various molecular mechanisms, including VOPP1-mediated relocation, which generates dosage-dependent WWOX functions in human cancers. The gene discussed is PTEN; the disease is cancer.